We did not find any statistically significant relationships between a possible increase in the serum levels of sVCAM-1, IL-1β, IL-6, TNF-α, or RANKL and the periodontal primary outcome among individuals with T2DM. This evidence concerns the gene TNFSF11 and type 2 diabetes mellitus.